India set to overhaul drugs and cosmetics legislation

By Lucy Whitehouse contact

- Last updated on GMT

India set to overhaul drugs and cosmetics legislation

Related tags: Pharmacology

India is moving towards a shake up in its cosmetics regulation in order to keep up with the rapid pace of today’s innovation, with its union cabinet having just withdrawn the country’s Drugs and Cosmetics (Amendment) Bill of 2013.

According to Catch News​, the cabinet has decided to withdraw the bill, which came as an amendment to the original 1940 Drugs and Cosmetics Act, as the amendment has meant the country is unable to regulate the latest industry developments appropriately in such areas as “stem cells, regenerative medicines, medical devices and clinical trials under the law”.

The cabinet is now in the process of drawing up new legislation, which is set to particularly clarify regulation requirements for the medical devices market, and separate their regulation from that of cosmetics more generally.

New authority

Looking ahead, Catch News reports that the Drug Controller General of India will be the central licensing authority for cosmetics, drugs and medical devices.

It will control the issuing, licensing, suspension and cancellation of licences for the import, export and manufacture of products, and regulate the standard quality expected from them.

For those products which fall below minimum standards, the new bill is set to also specify conditions under which they will be considered misbranded, adulterated or spurious, and outlines the penalties for these breaches.

Starting from scratch

Wider consultations have been recommended for the formulation of the new legislation, and the Ministry of Health is expected to hold various sessions with interested groups and departments.

The cabinet has made clear that the incoming legislation will be in the form of a new bill rather than an amendment, in order to be able to address current industry demands fully.

"The Cabinet has, keeping in view the role of the sector in managing public health, decided that it will not be appropriate to carry out further amendments in the present Act,"​ it confirmed in a statement.

Related news

Related products

show more

Sensiva™ go natural,a protector without compromise

Sensiva™ go natural,a protector without compromise

Ashland Global Holdings Inc | 24-Jun-2022 | Technical / White Paper

Consumers are increasingly buying natural, organic beauty and wellbeing products as noted from the increasing number of product launches with natural claim...

Formulating for Clean Beauty

Formulating for Clean Beauty

Elementis | 26-May-2022 | Product Brochure

Water scarcity and water pollution continues to be a concern for the environment. Every year, about 130 tons of microplastic particles from personal care...

Caressense™ biofunctional, powering ageless beauty

Caressense™ biofunctional, powering ageless beauty

Ashland Global Holdings Inc | 01-May-2022 | Data Sheet

For the first time, Ashland researchers reveal a natural bioactive that can activate skin’s sensors of touch, the piezos, to release “feel-good” and anti-aging...

Related suppliers

Follow us


View more


Indie Pioneers Podcast

Indie Pioneers Podcast